Dividend Growth Market Leaders
17.49k followers • 11 symbols Watchlist by The Motley Fool
Companies that not only tend to beat the market, but pay you as they do.
Curated by The Motley Fool
Dividend Aristocrats are the model of consistency. To be a part of the club, a company must be a member of the S&P 500 index and have increased its annual dividend payment for the last 25 years. Many associate the group with income investing and dividend growth, but Dividend Aristocrats have beaten the broader market in total returns, notching better results over one-,three-, five-, and 10-year periods. Within this group of quality companies, our analysts like 10 in particular for investors looking for steady stable income (and some growth too!).
How did we choose these stocks?Each of these stocks is not only a Dividend Aristocrat but also an active recommendation of a Motley Fool premium investing service as of 8/31/2016.
Who made these selections?The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.
How are these weighted?This watchlist consists of equally weighted stocks.
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| Dividend Growth Market Leaders | -0.32% | +1.48% | +23.44% | +14.86% |
| ^GSPC | -0.22% | -3.23% | +20.62% | +5288.30% |
11 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| XOM | Exxon Mobil Corporation | 118.52 | -0.11 | -0.09% | 4:02 p.m. EDT | 13.80M | 18.02M | 469.13B |
| JNJ | Johnson & Johnson | 145.74 | +0.97 | +0.67% | 4:00 p.m. EDT | 7.10M | 7.41M | 351.20B |
| KO | The Coca-Cola Company | 58.91 | +0.40 | +0.68% | 4:00 p.m. EDT | 9.23M | 14.12M | 253.97B |
| MCD | McDonald's Corporation | 270.98 | +1.03 | +0.38% | 4:00 p.m. EDT | 3.38M | 3.33M | 195.38B |
| MDT | Medtronic plc | 79.19 | +0.11 | +0.14% | 4:00 p.m. EDT | 5.21M | 6.36M | 105.15B |
| SHW | The Sherwin-Williams Company | 309.38 | -0.78 | -0.25% | 4:00 p.m. EDT | 1.12M | 1.37M | 78.61B |
| CTAS | Cintas Corporation | 662.44 | -6.07 | -0.91% | 4:00 p.m. EDT | 212.12k | 353.06k | 67.21B |
| EMR | Emerson Electric Co. | 109.31 | -0.50 | -0.46% | 4:00 p.m. EDT | 1.40M | 2.77M | 62.49B |
| AFL | Aflac Incorporated | 80.98 | +0.72 | +0.90% | 4:00 p.m. EDT | 2.13M | 2.33M | 46.60B |
| MKC | McCormick & Company, Incorporated | 72.7 | +0.43 | +0.59% | 4:00 p.m. EDT | 1.33M | 2.14M | 19.51B |
- Reuters
US FDA mandates label updates on CAR-T cancer therapies
The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called "boxed warning" to highlight the serious risk of T-cell blood cancer in patients who use these therapies. The health regulor has required related updates to other sections of the label such as warnings and precautions, postmarketing experience, patient counseling information and medication guide. In January, the FDA asked a host of drugmakers including Gilead Sciences, Johnson & Johnson and Novartis to add a boxed warning to their CAR-T cancer therapies, as it received reports of patients developing a type of T-cell blood cancer after being treated with them.
PR NewswireAflac Incorporated Revises Time of First Quarter Webcast Teleconference to 7:00 a.m. (ET) on Thursday, May 2, 2024
Aflac Incorporated (NYSE: AFL) announced today that it has revised the time of its first quarter webcast teleconference call on Thursday, May 2, 2024 to 7:00 a.m. (ET), which is one hour earlier than the originally scheduled 8:00 a.m. start time, to avoid timing conflicts with other industry webcasts.
ReutersJ&J wins trial over Florida woman who claimed its baby powder caused her cancer
A Florida jury on Thursday concluded that Johnson & Johnson's baby powder talc product did not cause the ovarian cancer of a Florida woman who died in 2019. The lawsuit was brought by family members of Patricia Matthey, a Sarasota County resident who used Johnson's baby powder daily from 1965 until August 2016, when she was diagnosed with ovarian cancer, according to her family's lawsuit. J&J's Worldwide Vice President of Litigation Erik Haas said the company was vindicated by the jury's decision.
